Comparison of disinfection effect between benzalkonium chloride and povidone iodine in nasotracheal intubation: a randomized trial.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
31 08 2019
Historique:
received: 15 04 2019
accepted: 21 08 2019
entrez: 1 9 2019
pubmed: 1 9 2019
medline: 18 6 2020
Statut: epublish

Résumé

Nasotracheal intubation can potentially result in microbial contamination from the upper respiratory tract to the lower respiratory tracts. However, an ideal nasotracheal disinfection method is yet to be determined. Therefore, we compared the disinfection effects between benzalkonium chloride and povidone iodine in nasotracheal intubation. Overall, this study enrolled 53 patients aged 20-70 years who were classified into classes 1 and 2 as per American Society of Anesthesiologists-physical status and were scheduled to undergo general anesthesia with NTI. Patients who did not give consent (n = 2) and who has an allergy for BZK or PVI were excluded from the study. The patients were randomly divided into two groups on the basis of the disinfection method: BZK (n = 26, one patient was discontinued intervention) and PVI (n = 25). 50 patients were assessed finally. The subjects' nasal cavities were swabbed both before (A) and after disinfection (B), and the internal surface of the endotracheal tube was swabbed after extubation (C). The swabs were cultured on Brain heart infusion agar and Mannitol salt agar. The number of bacteria per swab was determined and the rates of change in bacterial count (B/A, C/B) were calculated. The growth inhibitory activity of the disinfectants on Staphylococcus aureus were also investigated in vitro. Although the initial disinfection effects (B/A) were inferior for benzalkonium chloride compared with those for povidone iodine, the effects were sustained for benzalkonium chloride (C/B). In the in vitro growth inhibitory assay against S. aureus, benzalkonium chloride showed higher inhibitory activity than povidone iodine. Although both disinfectants were inactivated or diffused/diluted over time, benzalkonium chloride maintained the threshold concentration and displayed antimicrobial effects longer than povidone iodine; therefore, benzalkonium chloride appeared to show a better sustained effect. Benzalkonium chloride can be used for creating a hygienic nasotracheal intubation environment with sustained sterilizing effects. UMIN-CTR (Registration No. UMIN000029645 ). Registered 21 Oct 2017.

Sections du résumé

BACKGROUND
Nasotracheal intubation can potentially result in microbial contamination from the upper respiratory tract to the lower respiratory tracts. However, an ideal nasotracheal disinfection method is yet to be determined. Therefore, we compared the disinfection effects between benzalkonium chloride and povidone iodine in nasotracheal intubation.
METHODS
Overall, this study enrolled 53 patients aged 20-70 years who were classified into classes 1 and 2 as per American Society of Anesthesiologists-physical status and were scheduled to undergo general anesthesia with NTI. Patients who did not give consent (n = 2) and who has an allergy for BZK or PVI were excluded from the study. The patients were randomly divided into two groups on the basis of the disinfection method: BZK (n = 26, one patient was discontinued intervention) and PVI (n = 25). 50 patients were assessed finally. The subjects' nasal cavities were swabbed both before (A) and after disinfection (B), and the internal surface of the endotracheal tube was swabbed after extubation (C). The swabs were cultured on Brain heart infusion agar and Mannitol salt agar. The number of bacteria per swab was determined and the rates of change in bacterial count (B/A, C/B) were calculated. The growth inhibitory activity of the disinfectants on Staphylococcus aureus were also investigated in vitro.
RESULTS
Although the initial disinfection effects (B/A) were inferior for benzalkonium chloride compared with those for povidone iodine, the effects were sustained for benzalkonium chloride (C/B). In the in vitro growth inhibitory assay against S. aureus, benzalkonium chloride showed higher inhibitory activity than povidone iodine.
CONCLUSION
Although both disinfectants were inactivated or diffused/diluted over time, benzalkonium chloride maintained the threshold concentration and displayed antimicrobial effects longer than povidone iodine; therefore, benzalkonium chloride appeared to show a better sustained effect. Benzalkonium chloride can be used for creating a hygienic nasotracheal intubation environment with sustained sterilizing effects.
TRIAL REGISTRATION
UMIN-CTR (Registration No. UMIN000029645 ). Registered 21 Oct 2017.

Identifiants

pubmed: 31470798
doi: 10.1186/s12871-019-0839-y
pii: 10.1186/s12871-019-0839-y
pmc: PMC6717375
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Benzalkonium Compounds 0
Povidone-Iodine 85H0HZU99M

Banques de données

UMIN-CTR
['UMIN000029645']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

168

Références

JAMA. 1976 Oct 4;236(14):1610-1
pubmed: 989137
Oral Surg Oral Med Oral Pathol. 1989 Mar;67(3):266-7
pubmed: 2927920
Br J Anaesth. 1978 Oct;50(10):1041-6
pubmed: 708545
Anaesthesia. 2010 Jan;65(1):8-11
pubmed: 19849677
Lett Appl Microbiol. 1999 Jan;28(1):7-12
pubmed: 10030024
Anesth Analg. 2005 Oct;101(4):1226-9, table of contents
pubmed: 16192550
Control Clin Trials. 1981 Jun;2(2):93-113
pubmed: 7273794
Ann Emerg Med. 1981 Mar;10(3):142-4
pubmed: 7469154
Pediatrics. 1980 Mar;65(3):487-90
pubmed: 7360535
Pediatrics. 1973 Mar;51(3):476-9
pubmed: 4541042
J Clin Anesth. 2014 Aug;26(5):390-4
pubmed: 25113425
Nebr Med J. 1984 Mar;69(3):68-9
pubmed: 6717669
Can J Anaesth. 2006 Mar;53(3):295-8
pubmed: 16527796
Am J Med Sci. 1982 May-Jun;283(3):129-40
pubmed: 7044125
Acta Anaesthesiol Sin. 1996 Jun;34(2):93-6
pubmed: 9084529
Anesth Analg. 1973 Nov-Dec;52(6):873-6
pubmed: 4796559
Anesth Analg. 1987 May;66(5):460-2
pubmed: 3578854
Chest. 1977 Jul;72(1):105-7
pubmed: 872639

Auteurs

Aiji Sato-Boku (A)

Department of Anesthesiology, Aichi Gakuin University School of Dentistry, 2-11 Suemori-dori, Chikusa-ku, Nagoya, 464-8651, Japan. bokuaiji@dpc.agu.ac.jp.

Keiji Nagano (K)

Department of Oral microbiology, School of Dentistry Health Sciences University of Hokkaido 757 Kanazawa, Ishikari-Tobetsu, Hokkaido, 061-0293, Japan.

Yoshiaki Hasegawa (Y)

Department of Microbiology, Aichi Gakuin University School of Dentistry, 1-100 Kusumotocho, Chikusa-ku, Nagoya, 464-8650, Japan.

Yuji Kamimura (Y)

Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Yoshiki Sento (Y)

Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

MinHye So (M)

Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Eisuke Kako (E)

Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Masahiro Okuda (M)

Department of Anesthesiology, Aichi Gakuin University School of Dentistry, 2-11 Suemori-dori, Chikusa-ku, Nagoya, 464-8651, Japan.

Naoko Tachi (N)

Department of Anesthesiology, Aichi Gakuin University School of Dentistry, 2-11 Suemori-dori, Chikusa-ku, Nagoya, 464-8651, Japan.

Hidekazu Ito (H)

Department of Anesthesiology, Aichi Developmental Disability Center Central Hospital, 713-8 Kagiya-cho, Kasugai-city, Aichi, 480-0392, Japan.

Yushi Adachi (Y)

Department of Anesthesiology, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showaku, Nagoya, 466-8550, Japan.

Kazuya Sobue (K)

Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH